Executive Summary
Today's M&A digest reveals a bifurcated US deal landscape: large-cap strategic consolidation (Baker Hughes/Chart Industries) versus distressed restructurings and SPAC extensions. The $4.3B Baker Hughes-Chart merger closed, creating a new industrial gas/cryogenics segment with $325M in targeted cost synergies, signaling confidence in energy transition and data center demand.
Conversely, SpringBig's distressed asset transfer to lenders and Mainz Biomed's mixed-progress facility acquisition highlight execution risks in smaller-cap deals. Plum Acquisition Corp. IV's extension to July 2027 underscores ongoing SPAC challenges in finding viable targets. Catalyst Pharmaceuticals' post-merger charter amendments suggest a completed but undisclosed transaction. Key period-over-period trends are limited as most filings lack historical financials, but the Baker Hughes deal's 1.0-1.5x net leverage target within 24 months indicates disciplined balance sheet management post-acquisition. The overarching theme is a 'haves vs. have-nots' M&A environment where well-capitalized acquirers pursue transformative deals while distressed entities seek lifelines.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US Merger & Acquisition SEC Filings digest from July 15, 2026.
Investment Signals (8)
- Baker Hughes ↓ (BULLISH)▲
Completed $4.3B Chart acquisition, creating third segment with $325M annualized cost synergies by year 3; net leverage target 1.0-1.5x within 24 months signals disciplined integration
-
Merger closed July 16, 2026; amended charter authorizes only 1,000 shares (from likely millions), indicating massive share consolidation/reverse split – watch for post-merger float dynamics [BULLISH for BKR, NEUTRAL for former CHRT holders]
-
Distressed restructuring extinguished ~$12.5M secured debt via asset transfer to lenders; new CEO appointed to pursue reverse merger – high-risk/high-reward shell play [SPECULATIVE BULLISH for turnaround seekers]
- Mainz Biomed (via Quantum Cyber) (MIXED BULLISH)▲
Acquired ~50,000 sq ft facility for $2.3M in Bridgeport, CT, targeting DoD's $55B FY2027 drone budget; equipment acquisition still pending – partial execution
- Plum Acquisition Corp. IV ↓ (NEUTRAL)▲
Extended deadline to July 16, 2027 with up to 6 monthly extensions; no target yet – SPAC time decay risk but optionality for investors
- Catalyst Pharmaceuticals ↓ (NEUTRAL)▲
Post-merger charter amendments (single class, 1,000 shares authorized) suggest completed acquisition; no financial terms disclosed – limited signal
- Baker Hughes ↓ (BULLISH)▲
Jim Apostolides appointed to lead Chart segment, has led integration since July 2025 – continuity reduces execution risk
- SpringBig ↓ (SPECULATIVE)▲
CEO Andrew Jay Glashow appointed July 10, 2026; company warns it may wind down if no transaction – urgency creates catalyst but high failure risk
Risk Flags (8)
- SpringBig/Distressed Restructuring↓ [HIGH RISK]▼
Transferred all operating assets to lenders, extinguishing $12.5M debt; parent is now a shell with no business, facing wind-up risk if no reverse merger found
- SpringBig/Default Triggers↓ [HIGH RISK]▼
Multiple note defaults including cash below $1M, CRA lien, unpaid taxes – indicates severe financial distress
- Mainz Biomed/Execution Risk↓ [MEDIUM RISK]▼
Equipment acquisition from Arcade Technology LLC still pending; facility acquisition closed but production ramp unproven – integration risk
- Mainz Biomed/Government Contract Dependency↓ [MEDIUM RISK]▼
Facility tied to Executive Order 14307 and DoD budget; any policy shift or budget delay could derail thesis
- Plum Acquisition Corp. IV/SPAC Time Decay↓ [MEDIUM RISK]▼
No target announced despite extension; if no deal by July 2027, SPAC must liquidate – trust value erosion risk
- Baker Hughes/Integration Risk↓ [MEDIUM RISK]▼
$4.3B deal with $325M synergy target; net leverage 1.0-1.5x within 24 months implies significant debt – any integration misstep could pressure balance sheet
-
Amended charter authorizing only 1,000 shares suggests massive reverse split; former shareholders may face liquidity and valuation uncertainty [MEDIUM RISK for former CHRT holders]
- Catalyst Pharmaceuticals/Opacity↓ [LOW RISK]▼
No financial terms disclosed for acquisition; charter amendments suggest significant corporate structure change – lack of transparency
Opportunities (7)
- Baker Hughes/Chart Synergies↓ (OPPORTUNITY)◆
$325M annualized cost synergies by year 3; Chart's exposure to nuclear, data centers, carbon capture, and space aligns with secular growth themes – potential EPS accretion
- Baker Hughes/Energy Transition Play↓ (OPPORTUNITY)◆
Chart's cryogenics and gas infrastructure capabilities position Baker Hughes for LNG, hydrogen, and carbon capture demand – thematic tailwind
- Mainz Biomed/Defense Drone Play↓ (SPECULATIVE OPPORTUNITY)◆
Facility in Bridgeport, CT targets DoD's $55B FY2027 drone budget; if equipment deal closes, could become pure-play autonomous defense manufacturer – high upside if execution succeeds
- SpringBig/Reverse Merger Shell↓ (SPECULATIVE OPPORTUNITY)◆
New CEO with mandate for strategic business combination; clean shell with no operating liabilities could attract private companies seeking public listing – distressed SPAC alternative
- Plum Acquisition Corp. IV/Extension Optionality↓ (OPPORTUNITY)◆
Extended timeline to July 2027 provides 12 months to find target; if quality deal announced, SPAC could re-rate – option value for patient investors
- Baker Hughes/Chart Commercial Synergies↓ (OPPORTUNITY)◆
Beyond cost cuts, cross-selling Chart's products into Baker Hughes' customer base could drive revenue upside not captured in $325M synergy target
- Chart Industries/Post-Merger Float↓ (OPPORTUNITY)◆
If share consolidation creates tight float, BKR stock could see institutional accumulation as new segment gains visibility – watch for analyst upgrades
Sector Themes (6)
- Large-Cap Strategic Consolidation◆
Baker Hughes/Chart ($4.3B) represents trend of energy majors acquiring specialized technology to capture energy transition and data center demand – expect more deals in cryogenics, carbon capture, and industrial gas
- Distressed Restructurings Rise◆
SpringBig's asset-for-debt swap highlights growing trend of cash-strapped small-caps transferring assets to lenders; watch for similar 'zombie' companies in tech and biotech
- SPAC Market Still Stalled◆
Plum Acquisition's extension to July 2027 (12 months out) reflects ongoing difficulty finding quality targets; SPAC sponsors are buying time amid elevated redemption rates and regulatory scrutiny
- Defense Tech M&A Acceleration◆
Mainz Biomed/Quantum Cyber's facility acquisition targets DoD drone spending; expect more small-cap defense tech M&A as FY2027 budget allocates $55B to autonomous warfare
- Post-Merger Charter Amendments Signal Structure◆
Both Catalyst Pharma and Chart Industries amended charters to single-class, low-share-authority structures post-merger – suggests reverse splits or holding company formations becoming standard practice
- Cross-Sector Synergy Pursuit◆
Baker Hughes' acquisition of Chart (industrial gas equipment) shows energy companies diversifying into data center cooling and nuclear – convergence of energy, industrial, and tech sectors
Watch List (8)
-
Watch for announcement of strategic business combination or wind-up; new CEO Glashow likely to provide update within 60-90 days
-
Monitor pending equipment acquisition from Arcade Technology LLC – if closed, stock could re-rate on defense contract potential
-
Q3 2026 earnings call (expected Oct) to discuss Chart integration progress, synergy realization, and net leverage trajectory
-
Monthly extension deadlines (first Jan 16, 2027) – any target announcement would be major catalyst; watch for shareholder redemptions
-
Post-merger trading under Baker Hughes; monitor for analyst initiation on new segment and any spin-off rumors
-
Watch for subsequent 8-K or 10-Q disclosing financial terms of the acquisition that triggered charter amendments
- DoD FY2027 Budget👁
Final approval expected late 2026; $55B drone allocation would validate Mainz Biomed/Quantum Cyber's thesis
- SEC SPAC Rule Changes👁
Any new regulations could impact Plum Acquisition's ability to complete deal or force liquidation
Filing Analyses
(6)
16-07-2026
Catalyst Pharmaceuticals, Inc. filed an 8-K on July 16, 2026, reporting the completion of an acquisition/disposition (Item 2.01) and related amendments to its certificate of incorporation (Items 3.01, 3.03, 5.01, 5.02, 5.03). The amended certificate authorizes only one class of common stock (1,000 shares, $0.001 par value) and includes standard provisions on director liability, indemnification, and exclusive forum (Delaware Chancery Court). No financial terms of the acquisition were disclosed in this filing.
- · The company is now authorized to issue only one class of stock (common stock), with 1,000 shares authorized at $0.001 par value.
- · The amended certificate includes exclusive forum provisions requiring derivative actions and fiduciary duty claims to be brought in the Delaware Court of Chancery.
- · Director liability is eliminated to the fullest extent permitted by Delaware law, and the company must indemnify directors and officers to the fullest extent.
16-07-2026
This 8-K filing by MAINZ BIOMED N.V. (MYNZ) contains a press release from Quantum Cyber N.V. (Nasdaq: QUCY), which appears to be the actual reporting entity. Quantum Cyber announced that its subsidiary, Quantum Drones Corporation, completed the acquisition of a ~50,000 sq ft industrial facility in Bridgeport, Connecticut for $2.3 million, closing on July 15, 2026. The acquisition is a key step in Quantum Cyber's strategic transition from a technology licensor to a vertically integrated autonomous defense manufacturer, positioning it to potentially participate in U.S. defense procurement, including the DoD's $55 billion FY2027 budget allocation for drone and autonomous warfare programs. However, the equipment acquisition under a separate Asset Purchase Agreement remains pending, and the company faces significant execution risks including integration, operational targets, and securing government contracts.
- · The real property acquisition was first announced via a Letter of Intent on June 8, 2026, and definitive agreements on June 29, 2026.
- · The equipment acquisition from Arcade Technology LLC under a separate Asset Purchase Agreement is still pending.
- · The facility is intended to support Executive Order 14307 on American drone dominance.
- · Quantum Drones Corporation is a Nevada-incorporated wholly owned subsidiary of Quantum Cyber N.V.
- · The company's stock is listed on Nasdaq under ticker QUCY (not MYNZ).
16-07-2026
Plum Acquisition Corp. IV shareholders approved an amendment to extend the deadline to consummate a business combination from January 16, 2027 to July 16, 2027, with the option for up to six monthly extensions. The amendment also modifies redemption provisions and voting requirements. This provides the SPAC additional time to find a target, but no specific acquisition has been announced.
- · The original deadline to complete a business combination was January 16, 2027.
- · The extension allows up to six additional one-month periods, pushing the final deadline to July 16, 2027.
- · The amendment was passed as a special resolution at an extraordinary general meeting on July 10, 2026.
- · Redemption rights for public shareholders are preserved if the company fails to complete a business combination by the extended deadline.
- · The amendment also updates voting requirements for business combination proposals and extension amendments.
16-07-2026
SpringBig Holdings, Inc. transferred substantially all of its assets (including its operating subsidiary SpringBig, Inc.) to secured lenders via a Delaware General Corporation Law Section 272(b) reorganization, extinguishing approximately $12.5 million in secured debt. The company has appointed Andrew Jay Glashow as CEO and director to pursue a strategic business combination, but warns it may wind down and dissolve if no transaction is completed. The filing reflects a distressed restructuring where the operating business was effectively handed over to creditors, leaving the parent as a shell seeking a reverse merger or similar transaction.
- · The Reorganization Agreement was entered into on July 13, 2026, and the CEO appointment was effective July 10, 2026.
- · The collateral transferred included all issued and outstanding equity interests in SpringBig, Inc., the operating subsidiary.
- · The company was in default under multiple provisions of its Notes, including cash balance below $1,000,000, a lien by Canada Revenue Agency against Beaches Development Group Inc., and failure to remit certain tax obligations.
- · The Board determined the fair market value of the collateral did not exceed the total secured obligations being eliminated.
- · No stockholder vote was required for the reorganization under DGCL Section 272(d).
- · The company's securities are no longer registered on any exchange (trading symbol listed as 'None').
- · Andrew Glashow qualifies as an 'audit committee financial expert' and has experience in reverse mergers and IPOs.
16-07-2026
Baker Hughes completed its acquisition of Chart Industries for $4.3 billion in revenue (FY2025), creating a new third operating segment. The deal is expected to generate $325 million in annualized cost synergies by year three, with additional commercial synergy upside. However, the company faces integration risks and a net leverage target of 1.0-1.5x within 24 months, reflecting the debt incurred for the transaction.
- · Chart will operate as a third reporting segment within Baker Hughes.
- · Jim Apostolides has been appointed senior vice president to lead the Chart segment; he has led integration since July 2025.
- · Chart serves sectors including gas infrastructure, nuclear, data centers, carbon capture and storage, space, and geothermal.
- · Baker Hughes targets net leverage of 1.0-1.5x within 24 months post-acquisition.
- · The filing includes forward-looking statements and risk factors related to integration, debt, and competition.
16-07-2026
Chart Industries, Inc. completed its merger with Tango Merger Sub, Inc., a subsidiary of Baker Hughes Company, on July 16, 2026. As a result of the merger, Chart Industries became the surviving corporation and its certificate of incorporation was amended and restated. The filing confirms the consummation of the transaction first announced on July 28, 2025, but does not disclose any financial terms or operational metrics.
- · The merger was effected under Section 251 of the Delaware General Corporation Law.
- · The surviving corporation retains the name 'Chart Industries, Inc.'
- · The amended certificate of incorporation authorizes only 1,000 shares of common stock at $0.01 par value, indicating a significant reduction from the pre-merger share count (likely a reverse stock split or share consolidation).
- · Article Eleven of the amended charter opts out of Section 203 of the DGCL (anti-takeover provisions).
- · The principal place of business remains at 8665 New Trails Drive, Suite 100, The Woodlands, Texas 77381.
Get daily alerts with 8 investment signals, 8 risk alerts, 7 opportunities and full AI analysis of all 6 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Merger & Acquisition SEC Filings
🇺🇸 More from United States
View all →July 16, 2026
US Pre-Market SEC Filings Roundup — July 16, 2026
US Pre-Market SEC Filings Roundup
July 16, 2026
USA Insider Trading Pulse — July 16, 2026
USA Insider Trading Pulse
July 15, 2026
US Pre-Market SEC Filings Roundup — July 15, 2026
US Pre-Market SEC Filings Roundup
July 15, 2026
S&P 500 Technology Sector SEC Filings — July 15, 2026
S&P 500 Technology Sector SEC Filings